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ABSTRACT 
 
Aim: To study the incidence and clinical profile of fungal sinusitis in diagnosed cases of chronic 
rhinosinusitis. 
Materials and Methods: This was a prospective study in which 100 patients with chronic 
rhinosinusitis who underwent treatment in the department of E.N.T at a tertiary care centre over 
two years were randomized into the study. Diagnosis was confirmed by fungal culture and 
pathological examination of the excised specimen. The data collected from the patients was 
analysed by Pearson Chi- Square and Fisher’s Exact tests. Patients underwent either endoscopic 
sinus surgery or medical line of management or a combination of both. 
Results: Fungal rhinosinusitis was more common in the elderly age groups with involvement of 
maxillary sinus in most of the cases. Nasal discharge, nasal obstruction and headache were the 
most common presenting symptoms. Pathological examination had a higher sensitivity than 
microbiology examination in the diagnosis. Mucor was the most commonly isolated organism. 
Fungal sinusitis was comparatively more common among immunocompetent individuals. More 
than one-third of cases were invasive fungal rhinosinusitis. Complications were more in cases of 
mucormycosis. Surgery with chemotherapy offered better treatment outcome as compared to 
single modality. 
Conclusion: Early detection and treatment of fungal rhinosinusitis is the key in tackling this 
clinical condition which can otherwise be fatal. 
 
Key words: chronic rhinosinusitis, fungal sinusitis, immunocompromised state, mucormycosis, 
aspergillus 
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INTRODUCTION 
 
Fungal infections of nose and paranasal sinuses are not uncommon as it was thought 
earlier. Fungal infections can occur in any individual but symptoms differ based on the 
immunity status of the patient.  A high index of suspicion is needed for diagnosis of 
fungal rhinosinusitis since most of the patients present with symptoms similar to other 
chronic sinus infections except for their resistance to conventional antibiotic therapy. 
Invasive fungal infections commonly occur in debilitated individuals with systemic 
illnesses like diabetes mellitus and other immunosuppressed states and it should be 
considered in the differential diagnosis of unknown factors for deteriorating general 
condition of these patients. 
   
The most common site of fungal infection is the lung, with or without haematogenous 
spread to other organs. A localized fungal infection can also occur in the upper 
respiratory tract and is probably more common than was previously suspected.  Fungal 
infections of the paranasal sinuses most often include histoplasmosis, coccidiomycosis, 
candidiasis, phycomycosis and aspergillosis. Aspergillus is the most common fungal 
pathogen in sinus disease and is the most common primary fungal organism infecting the 
maxillary antrum. Aspergillus is a fungus of the Ascomycetes class that occurs 
worldwide and may appear as a saprophyte, parasite or frank pathogen in man.  It is 
found in many of the moulds on food, fruits, grain seeds and plants. Its ubiquitous spores 
present in dust enter the respiratory system of man where under proper climatic 
conditions they become pathogenic. 
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The occurrence of fungal sinusitis in healthy individuals was first reported by Zarniko in 
1891 when he isolated Aspergillus fumigatus from the antrum of a patient who presented 
with symptoms of chronic maxillary sinusitis.  Since 1968 the number of reported cases 
of aspergillosis of the nose and paranasal sinuses has increased more than threefold.  
Most reports of mycotic infections of the maxillary sinus in healthy individuals have been 
solitary ones where the diagnosis was made either at surgery or post operatively in 
patients presenting with typical features of chronic bacterial sinusitis, resistant to 
conventional methods of therapy.  It may be that aspergillosis of the maxillary sinus is 
much more common than reported. 
 
This disease entity is being increasingly recognized, because of increased awareness, 
improved techniques of specimen collection, processing, fungal culture and special 
staining for pathological examination. 
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            REVIEW OF LITERATURE 
American Academy of Otolaryngology recommended that the term rhinosinusitis is more 
accurate over sinusitis to describe the disease involving nose and paranasal sinuses. Fungi 
are eukaryotic unicellular filamentous organisms of ubiquitous nature. Majority of fungi 
exist as soil saprophytes and few as parasites of humans and animals. Most of the human 
fungal infections are opportunistic. The incidence of fungal infections and especially the 
morbidity and mortality caused by them have been grossly under-estimated. Another 
major reason for the rapid increase in the number of fungal rhinosinusitis cases is higher 
prevalence of immunocompromised patients.  
 
McGuirt and Harill7 identified Aspergillus as the most commonly encountered pathogen 
in the nose and paranasal sinuses. 
 
Plaignaud was the first to report a case of possible fungal sinusitis in a 22 year old soldier 
with maxillary pain. 
 
Paultauf in 1884 was the first to describe a definite case of fungal sinusitis. In 1885, 
Schubert reported a case of non-invasive aspergillosis involving the paranasal sinuses. 
 
Since 1968, the number of reported cases has increased more than three folds. In 1972, a 
review of world literature by Zinneman revealed 37 cases of fungal sinusitis, of which 17 
were reported by Milosev and Magoub3 from Sudan. 
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Mirsky and Cuttner in 1972 found severe fungal infection at autopsy in 28% of patients 
who died of acute leukemia. 
 
In 1979, Jahrsdoefer et al in his review of world literature found 103 cases of fungal 
sinusitis most of which were solitary case reports. 
 
Cho Choi in 1979 found fungal infection in 22% of patients who died of acute leukemia. 
Glass and Hertzanu in 1984, reviewed world literature and found 115 case reports of 
Aspergillus sinusitis. 
 
Stammberger15 in 1985 reported of having treated over 140 patients with massive fungal 
sinusitis in the period of 1976-1985. 
 
Mayo clinic reported 12 cases of Aspergillus sinusitis over a period of 13 years from 
1972 – 1985. 
 
Hazarika et al12 in 1984 reported three cases of rhinocerebral mucormycosis, all of them 
were elderly and diabetic. 
 
Chakrabarti et al40 in 1992 isolated fungi in 50 of 119 clinically suspected cases in North 
India over a two-year period. 
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The reported incidence of fungal sinusitis varies widely with very high rate appearing in 
the European countries. According to literature review highest incidence of allergic 
fungal rhinosinusitis (AFRS) was noted in Mumbai, India (Ferguson et al 2000). 
 
ANATOMICAL CONSIDERATIONS: 
The development of nose is from the structures surrounding the primitive stomodeum, 
namely the mesenchymal processes i,e…frontonasal process and  maxillary processes. 
Thickenings of ectoderm called olfactory placodes which appear above the stomodeum 
develop into olfactory pits. These olfactory pits at 5-7 weeks of gestation extend 
posteriorly to form nasal cavities. The fusion of maxillary process with the lateral nasal 
process occurs at the nasolacrimal groove which later develops into the nasolacrimal 
duct. The maxillary process also fuses with the median nasal process leading to formation 
of lateral part of the upper lip. 
 
The Nasal septum and premaxilla are formed by the fronto-nasal process.   
Evaginations of mucus membrane from nasal cavities on either side develop into various 
paranasal sinuses. 
 
Maxillary sinus develops due to expansion of primitive ethmoidal infundibulum into the 
mass of maxilla and is the first sinus to appear at 7-10 wks of gestation. Maxillary sinus 
expands in childhood with development of maxilla & teeth and attains adult size in the 
latter part of the second decade of life. 
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Anterior and Posterior ethmoid sinuses develop as an outpouching of lateral nasal wall in 
the middle meatus region at third month of gestation. Posterior ethmoid cells develop 
from the region of the superior meatus. Ethmoid sinuses reach adult size by 12 years of 
age. 
 
Frontal recess expands and further growth occurs superiorly to form frontal sinus which 
becomes radiologically visible by 7-12 years of age. They are asymmetrical since they 
develop separately. 
  
Sphenoid sinus develops from the nasal capsule of the embryonic nose. It is 
underdeveloped till 3 years of age after which there is more rapid growth. Complete 
pneumatization of the sphenoid sinus occurs by 9-12 years of age. 
 
The development of nasal cavities begin at the external nares and extends upto the 
posterior choanae. In adults the nasal cavities measure around 5-7 cm in length and 2-
5cm in height. They are narrowed transversely. 
 
Vestibule is skin-lined, dilated passage of the nasal cavity from external nares to the nasal 
fossa which contains sebaceous glands and sweat glands. Also contains hair follicles. 
 
Floor of the nose: Palatal process of maxilla constitutes anterior three-fourths of the floor 
while the rest one-fourth is constituted and remaining part is formed by horizontal 
process of palatine bone. 
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Roof of the nose: Nasal bone and nasal part of the frontal bone forms the anterior part of 
the roof while the middle part is formed by the cribriform plate of the ethmoid bone. Part 
of body of sphenoid bone forms the posterior part of the roof. 
 
Nasal septum or the medial wall is anteriorly formed by the quadrangular cartilage & 
premaxilla, posteriorly by the perpendicular plate of ethmoid & the sphenoidal crest. 
Inferior part of the nasal septum is constituted by crests of vomer, maxillary and palatine 
bones. 
 
Lateral nasal wall is anatomically is more complex, receiving the openings of paranasal 
sinuses. The most prominent structures on the lateral wall are the three turbinates namely 
inferior, middle and superior. A fourth turbinate, supreme turbinate may be seen in 60% 
of cases. Air passages below and lateral to turbinates are called meati, named after the 
respective turbinate. The site of drainage of the sphenoid sinus is the sphenoethmoidal 
recess, which is the area that lies above the superior turbinate and below the body of 
sphenoid. The frontal, anterior & middle ethmoids and the maxillary sinuses which 
comprises of the anterior group of sinuses drain into the middle meatus, whereas the 
posterior ethmoid sinuses drain into the superior meatus. The Nasolacrimal duct opens 
just anterior to the junction of the anterior 1/3rd and middle 1/3rd of the inferior turbinate 
in the inferior meatus. 
 
 19 
 
 
     Fig.1 Lateral nasal wall 
 
Inferior turbinate is composed of an independent bone covered with periosteum. It 
articulates with the inferior margin of the maxillary hiatus, ethmoid, palatine and lacrimal 
bones. Contains soft tissue with cavernous plexus with sinusoids submucosally which 
become engorged with blood in response to triggers or part of nasal cycle. 
 
 Agger nasi is part of the lateral nasal wall anterior to the middle turbinate insertion 
which is usually pneumatized. Agger nasi is part of the anterior ethmoid labyrinth. 
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The middle turbinate is a part of ethmoid labyrinth. The orientation is along 3 different 
planes. Anterior 1/3rd of the middle turbinate is along the sagittal plane and is attached 
superiorly to lateral nasal wall and cribriform plate. The middle 1/3rd of the middle 
turbinate has a coronal orientation, forming the basal lamella of the middle turbinate. 
Anterior to basal lamella, the ethmoid cells drain into middle meatus and posterior to it, 
the ethmoid cells drain into superior meatus. The posterior 1/3rd of the middle turbinate 
runs in the axial plane and gets inserted adjacent to sphenopalatine foramen. 
 
Frontal recess is an important structure where the lateral margin is formed by the lamina 
papyracea, bounded medially by middle turbinate, agger nasi anteriorly and ethmoid 
bulla posteriorly. 
 
The uncinate process, bulla ethmoidalis and hiatus semilunaris are the important 
structures in the middle meatus from anterior to posterior direction. 
 
The uncinate process is a thin crest of bone, the free border of which is parallel with the 
anterior surface of bulla ethmoidalis.  Ethmoid bulla is a rounded elevation formed by the 
middle ethmoidal cell. Hiatus semilunaris is a deep semi-circular sulcus below the 
ethmoid bulla. Opening of frontal sinus present in the infundibulum located at the 
anterior end of hiatus. Maxillary sinus opening is in the posterior part of hiatus. Anterior 
and middle ethmoidal sinuses open into the upper margin of bulla. Osteomeatal complex 
includes structures draining into middle meatus i,e…maxillary sinus ostium, anterior 
ethmoidal cells and frontal recess. 
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     Figure.2 
  
Maxillary sinus (Antrum of Highmore) occupies the body of maxilla and is pyramidal in 
shape, the base of which is at the lateral wall of the nose and the apex projecting into the 
zygomatic process. It is the largest among paranasal sinuses. Maxillary sinus is bounded 
anteriorly by the maxillary face, medially by the ascending process of the palatine bone 
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and posteriorly by the pterygomaxillary space. Maxillary ostium is in the anteromedial 
aspect of sinus near the roof of the sinus cavity hence mucociliary clearance is not gravity 
dependent and starts in a star-like pattern from the floor of the maxillary sinus towards 
the maxillary ostium. 
 
Frontal sinus: They are asymmetrical in shape, situated between the inner and outer tables 
of the frontal bone draining into each other or draining separately. Formation of frontal 
sinus occurs by growth and pneumatization of the ethmoid labyrinth into the frontal bone. 
Frontal sinus drainage occurs through the infero-medial aspect through the frontal ostium 
into middle meatus via the frontal recess. Frontal recess has various shapes depending on 
pneumatization of the air cells at its base, also depending on the anatomy of structures 
surrounding it. 
 
Ethmoid sinus:  Located within the ethmoid labyrinth, the collection of cells is called 
ethmoid sinuses, which lies lateral to the nasal cavity and medial to the orbit.  Ethmoid 
sinus is in the shape of a pyramid.  Fovea ethmoidalis is the roof of the ethmoid labyrinth 
which is much thicker than the rest of the bony structures in the region.  Lateral wall is 
formed anteriorly by frontal and lacrimal bones while it is constituted posteriorly by a 
paper thin bone called lamina papyracea which delineates the ethmoid sinus from the 
orbit per se. 
 
Sphenoid sinus:  Complete pneumatization of sphenoid sinus occurs only by 9 – 12 years 
of age and is quite variable in nature. The wall and roof of the sphenoid sinus are the 
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thinnest. Sphenoid sinus lies adjacent to vital structures like the internal carotid artery, 
optic nerve, vidian nerve, cavernous sinus and foramen rotundum. 
    
  
             Fig.3 Coronal section showing ethmoid and sphenoid sinuses 
 
Pseudostratified ciliated columnar epithelium lines the sinonasal cavity. Ciliated 
columnar epithelium lines most of the areas in the respiratory tract. The other cells 
present are basal cells which are pluripotent and secretory cells like goblet cells. The 
mucociliary flow is around 1 cm/min and is not gravity dependent. 
 
Physiological importance of paranasal sinuses: 
(a) Inspired air gets conditioned 
(b) Voice resonance 
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(c) Acts as shock absorber to the head and reduces the weight of skull bones 
(d) Moistens the nasal chambers 
(e) Provide thermal insulation for the brain 
(f) Plays a role in growth of facial skeleton 
 
MYCOLOGY: 
Fungi belong to the group of eukaryotic organisms. These organisms are characterized by 
a very rigid cell wall made up of polysaccharides like mannan and chitin which have high 
molecular weight. The cell membranes of these organisms contain sterols. 
 
Growth cycle of fungi23: 
Fungi usually have two phases of development namely vegetative phase and reproductive 
phase. Fungi undergo both these phases of life cycle or either one of these phases. 
Vegetative phase is usually the haploid phase wherein the fungi exist as yeast or mould 
forms. Reproduction in the case of fungi occurs by asexual or sexual means, namely 
mitotic or conjugative process. Telomorphs are the sexual forms while the asexual forms 
are anamorphs. 
 
Classification of fungi is into four groups based on mode of sexual reproduction and 
morphology. 
a) Ascomycetes             eg.   Histoplasma, Aspergillus 
      b) Zygomycetes  eg. Rhizopus, Mucor 
      c) Dueteromycetes eg. Alternaria, Candida 
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      d) Basidiomycetes   eg. Cryptococcus 
 
Mycosis23 is generally defined as infection caused by fungi.  Based on the mode of entry 
of the organism and site of entry, they are classified into: 
 Superficial mycoses  eg. Tinea corporis, Tinea pedis 
 Sub-cutaneous mycoses eg. Mycetoma 
 Systemic mycoses  eg. Histoplasmosis, Coccidiomycosis, 
 Opportunistic mycoses eg. Aspergillosis. 
 
Diagnosis of fungal infections23: 
Microscopic Examination: 
Microscopic examination of specimens for fungi or fungal elements is important in the 
diagnosis where diagnosis can be obtained prior to culture. 10% potassium hydroxide 
(KOH) is the most commonly used medium, making fungal structures readily visible by 
dissolving the human tissues.  Optical brighteners like Calcofluor white also aid in 
diagnosis. 
 
Fungal Culture: 
After collecting the clinical specimen for culture prior to antifungal therapy, multiple 
media are used for culturing the organisms. An appropriate temperature of 
30oCentrigrade must be maintained for an incubation period which varies from several 
days to weeks which again depends on the medium and fungi cultured. 
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Serological diagnosis: 
When fungal cultures are nonproductive, immunological tests are used to confirm the 
diagnosis.  Alteast a fourfold increase in antibody titre is needed for serological tests like 
Complement Fixation Test (CFT), Immuno-diffusion (ID), Enzyme Linked 
Immunosorbent Assay (ELISA), Latex Agglutination (LA) and Radioimmuno Assay 
(RIA) to be diagnostic. Detection of specific IgM antibody for a species of fungi is 
considered significant. 
 
Histopathological examination49: 
The gold standard investigation for invasive fungal rhinosinusitis is histology showing 
presence of fungal organisms. Though this process is more elaborate and time 
consuming, it is the only method to determine tissue invasion. 
Hematoxylin and Eosin (H&E) staining is very useful but is unable to delineate the 
fungal cell wall. Silver staining is the most sensitive staining method, but however its 
disadvantage is that silver stains the cells too dark. A more specific but less sensitive 
method than silver stain is Periodic Acid Schiff (PAS) stain which allows the study of 
fungal morphology since it stains less dark than silver stain. When a mould is suspected 
in a tissue material, Fontana Masson (FM) stain for melanin can be used as a differential 
stain. 
 
PATHOPHYSIOLOGY OF FUNGAL SINUSITIS:  
A variety of causative factors play a major role in the development of fungal sinusitis.  
The common pathway is sinus obstruction causing impaired ventilation leading to 
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fungal organisms becoming pathogenic. 
 
Environmental and Occupational factors: 
A hot humid dusty low hygienic environment usually is a predisposing factor to 
development of mycotic infections of paranasal sinuses especially in people engaged in 
farming and in agriculture industries in tropical countries. 
 
Host-factors50: 
I. Barrier defense which comprises of intact lining epithelium forms the basic mode of 
defense mechanism against fungal organisms. Any breach in the lining epithelium which 
can be a result of wide range of factors including trauma and any surgical intervention 
can make the patient susceptible to fungal infection. 
 
II. Antagonism by bacterial flora: The bacterial flora inhabiting the upper airway inhibits 
the colonization by fungi by competing with them for nutrient supply and by producing 
substances which inhibit their growth. 
 
III. Non-immune host factors: Mucociliary clearance is the basic mechanism of 
elimination of fungal spores which get lodged in the upper airway. Factors like 
transferrins which are present in serum promote phagocytosis of fungal organisms. 
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IV. Cellular immunity: This modality forms the mainstay among host defense 
mechanisms by antigen processing, macrophage activation, monocyte-macrophage 
activity and secretion of interleukin-2 and -interferon. 
 
V. Iatrogenic factors which predispose to fungal infection are: 
 Patients who are on long-term antibacterial therapy 
 Patients who are on steroid therapy for a long period of time, since corticosteroids 
depress leucotaxis 
 Chemotherapy which leads to granulocytopenia leading to immunocompromised 
state. 
 
Medical conditions50 that confer susceptibility to fungal infections are: 
Condition Defect 
AIDS Cell mediated immunity 
DiGeorge Syndrome, Thymic dysplasia Cell mediated immunity 
Hodgkin’s disease Cell mediated immunity 
Diabetes mellitus Depressed PMN function 
Chronic granulomatous 
diseases & myeloperoxidase deficiency 
Depressed PMN function 
Leukemia Depressed PMN function 
Bronchitis Depressed mucociliary action 
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Classification of fungal rhinosinusitis (FRS)8,64: 
Fungal rhinosinusitis can be defined as a spectrum of diseases caused by fungal 
organisms. This entity is divided into two basic types based on course of the disease 
which in turn depends on the relationship of the fungal organisms to their hosts:  
1. Invasive 
2. Non-invasive 
 
They are further divided into 5 distinct entities along the immunological spectrum64. 
Host 
defense 
Immunocompromised               Immunocompetent Atopy 
Fungal 
form 
1. Invasive 2. Granulomatous      3. Saprophytic       4. Fungal ball 5. AFRS 
 
With change in the immunologic status of patient, the non-invasive form of FRS becomes 
invasive in nature5. Immunologic condition of the host plays a more important role than 
the type of fungal organism affecting the host64. Leucopenia in bone marrow transplant 
patients, organ transplant recipient on anti-rejection medication, AIDS patients and 
diabetics who are immunocompromised are susceptible to invasive disease. 
 
Acute invasive fungal rhinosinusitis is less than 4 weeks duration where vascular 
invasion is prominent on histology64. 
 
Chronic invasive fungal rhinosinusitis is more than 4 weeks duration where vascular 
invasion is absent or minimal. 
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Paranasal Aspergillosis is categorized into two forms by McGuit and Harill7: 
i)  A localized form with no associated underlying disease 
ii) An invasive form especially in immunocompromised individuals 
 
ALLERGIC FUNGAL RHINOSINUSITIS (AFRS)72: 
Allergic fungal rhinosinusitis (AFRS) is the most common type of fungal rhinosinusitis. 
The term allergic fungal rhinosinusitis was introduced by Robson et al in 1989. Ponikau63 
et al claimed that most patients with chronic rhinosinusitis satisfy the criteria for Allergic 
Fungal Sinusitis81. 
 
AFRS and allergic bronchopulmonary aspergillosis (ABPA) share the same aetiology 
(Miller’s group; Katzenstain), mediated by both type-I (IgE mediated) and type-III (IgG 
antigen immune complexes). 
 
Type-I (IgE mediated) sensitivity to Aspergillus fumigatus was first demonstrated by 
Miller.  Alternaria, Curvularia, Bipolaris (Schubert & Goetz), Dreschslera, Exserohilum 
are the most common organisms associated with AFRS. 
 
AFRS is now a more widely encountered type of FRS. Individuals belonging to the 
younger age groups on an average 23-42 years are more prone to AFRS. In the study 
conducted by Manning37 & Holman, a male predominance was noted for AFRS. Warm 
 31 
 
and humid climate favour the prevalence of AFRS. Cody et al45 described that asthma 
and aspirin sensitivity are seen in one-third to half of AFRS patients. 
 
Marple 70,14 has given a graphical representation of the event of AFRS. 
 
             Fig.4 
The pathophysiology of AFRS is initiated when inhaled fungi gets deposited in the 
sinuses triggering an immunologic reaction (type I along with possibly type III) takes 
place in an atopic individual. Mucosal edema caused by the immunologic reactions lead 
to stasis of secretions along with accumulation of inflammatory exudate leading onto 
obstruction of sinus ostia. This phenomenon may expand to adjacent sinuses producing 
expansion of the involved sinus. 
 
Symptomatically AFRS is similar to other varieties of chronic rhinosinusitis with a 
history of nasal polyposis. Three quarter of AFRS patients give a typical history of 
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discharging dark rubbery nasal crusts containing tenacious allergic mucin containing 
fungal elements which appear as hyphal forms.  
 
Bent & Kuhn69,5 developed the following diagnostic criteria for AFRS: 
 Major criteria: 
 Type – I hypersensitivity 
 Nasal polyposis 
 Characteristic CT scan findings 
 Positive fungal smear or culture 
 Allergic mucin with fungal elements with no evidence of tissue invasion 
 
 Minor criteria: 
 Asthma 
 Unilateral disease 
 Radiographic evidence of bone erosion 
 Fungal culture positivity 
 Presence of Charcot - Leyden crystals 
 Serum eosinophilia 
 
Marple73,14 in his study excluded the necessity of having a positive fungal culture since a  
negative culture can be due to laboratory error and a positive culture may not always be 
accurate since it could be because of a saprophytic fungal growth. 
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The typical CT Scan finding noticed in AFRS is unilateral disease with hyper attenuated 
central areas within a sinus cavity. This CT finding corresponds to areas of hypointensity 
on T1 weighted MR images and signal void on T2 weighted MR images.  The dura and 
periorbita are not breached69. 
 
AFRS usually produces tan to green, brown or black coloured mucus which is thick and 
tenaceous. Eosinophils, Charcot - Leyden crystals and fungal hyphae may be seen on 
H&E staining. However Charcot – Leyden crystals are well seen with Brown-Benn stain 
since they are made up of lysophospholipase. Fungal elements in allergic mucin are 
typically stained by GMS stain69. 
 
The work-up69 for suspected AFRS should include: 
 Total eosinophil count 
 Total serum IgE and antigen-specific IgE antibody 
 Mucin obtained intraoperatively is subjected to microscopic examination and 
fungal culture 
 Antigen-specific IgG antibody 
 Precipitating antibodies 
 
The management of AFRS is exteriorization of sinuses followed by nasal irrigation along 
with administration of systemic steroids and topical steroids. Long term steroid usage in 
such cases can be avoided by resorting to antigen-specific immunotherapy along with 
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antifungal agents. Recurrence of the disease can also be avoided by the same modality of 
management. 
 
Surgical management of AFRS: 
McGuirt et al7 in their study conducted in 1979 found that removal of the diseased sinus 
mucosa, allowing good aeration and hence maintaining satisfactory drainage is very 
crucial in the surgical outcome of AFRS. For AFRS, more conservative surgical approach 
is now preferred over traditionally radical procedures. In their paper published in 1998, 
Mabry et al70,79 described this mode of surgery as conservative but complete.  
 
Goals of surgical management of AFRS: 
1. Removal of allergic mucin and fungal debris which usually has the highest 
antigenic load and hence reducing the same 
2. Establish ventilation and permanent drainage to all involved sinuses  
3. To establish a post-operative access to all involved sinuses for irrigation purpose 
 
Post-operative care mainly involves nasal irrigation, endoscopic evaluation of post-
operated sinonasal cavity and debridement of the operated cavity if necessary.  
 
Endoscopic mucosal staging system in AFRS71: 
A staging system was devised by the endoscopic follow-up based on mucosal response to 
medical management by Kupferberg et al80. 
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Stage 
 
Endoscopic findings 
0 No mucosal edema or allergic mucin 
I Mucosal edema with or without allergic mucin 
II Polypoid edema with or without allergic mucin 
III Sinus polypi with fungal debris or allergic mucin 
 
In the treatment protocol formulated by the Georgia nasal and sinus institute26, AFRS 
patients undergo Endoscopic Sinus Surgery (ESS) followed by initiating oral 
prednisolone by second day of surgery at 0.4 mg/kg for 4 days, then is gradually tapered 
and continued till one month post-operatively. Dosage of prednisolone in the 
postoperative period is based on the maintenance of stage ‘0’ according to the endoscopic 
mucosal staging system in AFRS. Oral prednisolone is tapered to a dose of 0.1 mg/kg if 
patient maintains in stage ‘0’ for 4 consecutive months. This is followed by initiation of 
intranasal steroid spray which is continued for at least a year. If patient continues to be in 
stage ‘0’ for an additional two months, oral prednisone can be stopped.  After which 
regular follow-up is required upto 5 years with endoscopy and serum IgE levels. 
 
Antifungal agents: 
Kuhn5 and colleagues in their study on the effectiveness of anti-fungal agents in AFRS 
revealed that Ketoconazole and Amphotericin-B were very beneficial drugs in preventing 
recurrence of the disease. 
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Immunotherapy: 
Ferguson64 reported that patients who received immunotherapy after initial control of 
disease with surgery responded well. For 12 index non-fungal pathogens and 11 common 
moulds allergic testing was done using intradermal titration methods and incorporated all 
positive reactors into treatment vial which were given on a weekly basis during the first 
year, on a biweekly basis in the second year and once in three weeks thereafter. 
  
FUNGAL BALLS: 
Fungal hyphae seen in a matted form is the major component of fungal balls seen in 
paranasal sinuses. In the spectrum of fungal sinusitis, this entity comes under the non-
invasive category seen in immunocompetent individuals. The first case was reported in 
1893 by Mackenzie. He described that this entity was more common among the 
individuals in older age groups with a female preponderance. According to the Mayo 
clinics9 review, fungal balls had an incidence of 3.7% and AFRS had a higher incidence 
of 69%. 
 
Pathogenesis:   
Fungal spores which enter the nasal cavity further gain entry into sinuses and germinate 
leading to formation of fungal balls. Fungal ball in paranasal sinuses present with 
symptoms similar to chronic rhinosinusitis including nasal blockage, nasal discharge and 
facial pain, the usually involved sinuses being maxillary sinus and sphenoid sinus in that 
order. 
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Opacification of involved sinus which maybe total or subtotal may be seen on imaging 
studies. Calcification or dense hyphae may appear as radio-densities in central soft tissue 
in around 50% of cases. 
  
Tangled hyphae with no evidence of tissue invasion is the typical histopathology in a case 
of fungal ball involving paranasal sinuses. In one-quarter to one-third of cases show 
positive fungal cultures. Most common organisms cultured are Aspergillus species, 
Alternaria and P.boydii. 
 
Surgical removal is the gold standard modality of treatment for fungal ball involving 
paranasal sinuses. Endoscopic large middle meatal antrostomy is sufficient for adequate 
clearance of fungal balls from maxillary sinus, though Caldwell-Luc surgery offers best 
chances to avoid recurrence.  
 
Only in immuno-compromised patients, fungal ball has a chance to become invasive FRS 
especially in cases of surgical trauma involving sphenoid sinus or lateral sphenoid body 
dehiscence. 
 
CHRONIC INVASIVE FUNGAL RHINOSINUSITIS: 
The classification of chronic invasive fungal rhinosinusitis into two entities namely 
granulomatous and non-granulomatous varieties was put forth by DeShazo et al54. 
Symptoms appear once there is erosion of bony margins occur, the most common bones 
involved being the orbit, the skull base and palatal bones. Due to bony involvement, the 
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symptoms appear after several months or years after onset of the disease. Symptoms 
include chronic headache and neurological symptoms like seizures, decreased mental 
status or focal neurological signs which are again due to erosion of the cribriform plate. 
In a study done in Sudan3, it was found that among patients who presented with 
granulomatous invasive fungal sinusitis, proptosis was the most common presenting 
feature. 
 
In cases of chronic invasive fungal rhinosinusitis, complications like cranial nerve 
deficits, cavernous sinus thrombosis, mycotic aneurysms and internal carotid artery 
rupture have been documented in rare instances. 
 
Severe congestion of nasal mucosa with polypoidal changes is usually seen on intranasal 
examination. Soft tissue with or without ulceration and slough may be seen. 
 
CT Scan of nose and paranasal sinuses show mucosal thickening, hyper-attenuated areas 
within the sinus cavity which maybe focal or diffuse, erosion of bony margins or 
expansion of the bony sinus cavity. Silverman and Mancuso in their study conducted on 
cases of chronic invasive fungal rhinosinusitis noted that infiltration of periantral fat 
planes around the maxillary sinus is one of the earliest evidence of invasive fungal 
disease. Neoplasms both benign or malignant and granulomatous lesions like syphilis and 
sarcoidosis are part of differential diagnosis. Ultimate distinction between invasive, non-
invasive forms and neoplasia is best made on histology and is regarded as the best means 
to distinguish the two forms of FRS. Examples of fungal organisms associated with 
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invasive form of fungal rhinosinusitis are Aspergillus species, Alternaria, Bipolaris, 
Candida, Curvularia, Drechsclera, Mucor, Sporothrix schenckii and Psedoallescheria 
boydii. 
 
Pathological examination shows typical periarterial inflammation without evidence of 
fungal elements or invasion of blood vessels. Veress described three types of invasive 
fungal rhinosinusitis, namely proliferative, exudative necrotizing and mixed forms.  
 
The management includes both surgery and anti-fungal therapy including agents like 
amphotericin-B or itraconazole though the use of steroids is contraindicated. 
 
SINONASAL MUCORMYCOSIS: 
Amongst fungal infections affecting man, the most fatal is sinonasal mucormycosis. 
Diabetics are more prone to acquire mucormycosis and in such cases diabetes becomes 
difficult to treat since it triggers further growth of fungus. This infection can occur in an 
individual in any immunocompromised state or in a normal individual. Platauf in 1885 
first reported the first case of mucormycosis involving the upper airway and coined the 
term ‘mycosis mucorina’. A case report of mucormycosis being successfully managed 
was first reported by Haris in 1955. The pathogenic species in this group are members of 
the family mucoraceae the most usual pathogen encountered being Rhizopus oryzae 
which contributes to 60% of all forms of mucormycosis reported and more significantly 
90% of all cases of rhinocerebral mucormycosis. 
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The factors which make an individual susceptible to mucormycosis include type-2 
diabetes mellitus, immunocompromised state during organ transplantation, 
haematological malignancies, immunodeficiency neutropenia, intravenous drug abusers 
and patients on long term steroids. This disease entity has a rapid progressive fulminant 
course when the host is severely immunocompromised. 
 
It takes 72 hours for the symptoms to manifest even in the case of an acute fulminant 
sinonasal mucormycosis. The most common symptoms seen among patients are fever, 
ulceration or necrosis of sinonasal mucosa and sometimes even periorbital or facial 
swelling which may be associated with reduced vision showing early signs of orbital 
cellulitis. Numbness over the face may be seen as an early symptom in a small percentage 
of cases. Infiltration of perisinus fat planes and bony erosion as seen in cases of chronic 
fungal rhinosinusitis is seen in radiographic imaging studies.   
 
Surgical modality of treatment without reversing the immunocompromised state of the 
individual is not beneficial. Systemic antifungal therapy and surgical debridement 
together form the pillars in management of this condition.  
 
ACUTE FULMINANT INVASIVE FUNGAL RHINOSINUSITIS80:  
Acute fulminant invasive fungal rhinosinusitis occurs due to tissue infiltration of 
sinonasal mucosa by the fungal organisms. The main objective of an otolaryngologist is 
to identify a case of invasive FRS at the earliest and to start treatment as soon as possible 
since this condition is fatal in 50-80% of cases, especially in those cases where it is 
 41 
 
complicated by orbital and intracranial complications. Usually occurs in patients in whom 
the neutrophilic response is impaired and in susceptible individuals within 2-3 weeks post 
bone marrow transplantation. Absolute neutrophil count is usually less than 500 cells/ml. 
 
Immunologic status of the individual and prominent vascular invasion on histology are 
the main prognostic factors. Acute fulminant invasive fungal rhinosinusitis usually begins 
with subtle symptoms. The commonest symptom is persisting fever of unknown origin 
(FUO) not responding to intravenous antibiotic therapy. Around 50% of patients have 
symptoms of facial and periorbital pain, nasal discharge, nasal blockage and headache. In 
the later stages, the manifestations include proptosis, ophthalmoplegia, loss of visual 
acuity, seizures, change in mental status and focal neurological signs.   
 
Diagnostic nasal examination include nasal mucosa discolouration which is due to 
ischemia or necrosis. Anatomical structures in the order of involvement are the middle 
turbinate in 67% of cases, followed by nasal septum (24%), palate (19%) and inferior 
turbinate (10%). Diminished sensation of the nasal mucosa and bleeding is suggestive of 
tissue invasion by fungal organisms. 
 
CT imaging helps in diagnosis, however the diagnosis is confirmed by histopathology 
examination. But before taking a biopsy, correction of thrombocytopenia (platelet count 
less than 60 x 109 /L) is mandatory.  
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Invasive fungal disease has histopathological diagnostic criteria which include: 
1. Submucosa shows presence of fungal hyphae which may or may not be 
associated with angiocentric invasion. 
2. Evidence of tissue necrosis with minimal host inflammatory response. 
 
The primary modality of treatment like in the previously described conditions is a 
combination of antifungal agents along with aggressive surgical debridement. Adequate 
surgical debridement is ensured when clear bleeding margins are obtained. Studies have 
proved that debridement slows down the progression of disease by reducing the fungal 
load and hence improving the efficacy of antifungal agents administered. Surgical 
debridement also provides specimen for fungal culture and histopathology examination.   
 
Prevention of Invasive Fungal rhinosinusitis: 
Prevention of invasive FRS in high-risk groups can be accomplished by nursing such 
patients in rooms with laminar airflow and by using high efficiency particulate air 
(HEPA) filters. Use of amphotericin nasal spray in patients who have undergone bone 
marrow transplantation has reduced the incidence of invasive FRS. Secondary 
prophylaxis is recommended for patients with a past history of invasive fungal disease 
and intravenous Amphotericin-B is the drug of choice.  
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Algorithm for diagnosis and management of invasive fungal rhinosinusitis75: 
 
     Figure. 5 
 
 
 
 
 
 
 
 44 
 
RATIONALE FOR STUDY 
 
 
 
Our institution, PSG Institute of Medical Sciences & Research at Coimbatore serves as a 
referral centre for the three southern states of India namely Tamil Nadu, Kerala and 
Andhra Pradesh which have an agricultural economy.  The warm moist climate with its 
attendant high rate of allergic, hypertrophic, vasomotor and infectious rhinosinusitis 
provides one of the pre-requisites for fungal sinonasal infections due to the altered 
physiology of upper airway. The presentation of patients with chronic fungal 
rhinosinsusitis can be varied causing dilemma in managing such a disease entity. 
 
Reviewing the available literature we realized that all the landmark studies on fungal 
rhinosinusitis were done in Europe and American continents. The living conditions of the 
general population, the lifestyle of people, methods of farming and vegetation in these 
countries are very different from that of India. The lack of recognition of this disease 
entity and the scarcity of reports prompted us to undertake this study. 
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AIMS OF THE STUDY 
 
 
1. To study the incidence of fungal sinusitis in diagnosed cases of chronic 
rhinosinusitis 
2. To study the clinical, radiological & microscopic features of fungal rhinosinusitis 
3. To study the aetiological basis of fungal rhinosinusitis 
4. To evaluate the various treatment modalities available 
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MATERIALS AND METHODS 
 
This is a prospective study in which evaluation of 100 patients with chronic rhinosinusitis 
who underwent treatment on an Out-Patient or In-Patient basis in department of E.N.T, 
PSG Institute of Medical Sciences & Research, Coimbatore, Tamil Nadu from July 2011 
to July 2013 were considered. 
 
History of every patient was taken in detail and importance was given to their presenting 
symptoms, both local and general. Any significant past history including type-2 diabetes 
mellitus, leukemia and tuberculosis was also elicited.  History of organ transplant, nasal 
surgeries and treatment history for the present symptoms like antihistamines, steroids, 
antibiotics or history of administration of chemotherapeutic agents were also given 
importance. 
 
All the patients were taken up for the study based on the clinical presentation namely 
nasal discharge, nasal obstruction, headache, facial pain, swelling over the face and 
sneezing and haziness of sinuses noted radiologically who did not respond satisfactorily 
to conventional antibiotic therapy. 
 
Inclusion Criteria for cases considered in the study:   
1. Age-group > 14 years 
2. Both genders 
3. Established diagnostic criteria for chronic rhinosinusitis 
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Exclusion Criteria for cases: 
1. Age-group < 14 years 
2. Patients unwilling to comply with the study 
3. Systemic diseases preventing participation in the study 
4. Patients diagnosed with underlying paranasal sinus malignancies 
 
All patients underwent diagnostic nasal endoscopy to rule out any changes of the 
osteomeatal complex, and to obtain specimen for fungal culture and pathology 
examination.  A nasal swab from the middle meatus was taken for fungal culture. CT 
scan of the nose and paranasal sinuses was done for all patients who could afford a scan. 
 
Evaluation: 
All 100 patients were worked up based on a proforma. The diagnosis was confirmed by 
fungal culture and histopathology examination of the excised specimen. The data 
collected from the patients was analysed by Pearson Chi- Square and Fisher’s Exact tests. 
Patients underwent either endoscopic sinus surgery or medical line of management or a 
combination of both. 
 
Follow-up: 
All the patients were followed up in the outpatient department of E.N.T, PSG Institute of 
Medical Sciences & Research. During follow-up, all patients were assessed clinically for 
improvement in symptoms following treatment. All the patients were analysed for their 
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improvement in symptoms namely nasal obstruction, nasal discharge, swelling over the 
face, headache, cold and sneezing. 
 
On follow-up also, repeat diagnostic nasal endoscopy was done, to evaluate the presence 
of nasal discharge, mass or any other pathology in the nose. The follow-up period usually 
ranges from two months to two years. 
 
LABORATORY TECHNIQUES FOR SPECIMENS: 
Specimen collection and transport for microscopic examination: 
The material obtained during diagnostic nasal endoscopy or surgery is subjected for 
potassium hydroxide (KOH) preparation, Gram staining and microscopic examination 
with hematoxylin and eosin staining for eosinophils. Microscopy also reveals Charcot-
Leyden crystals which is a characteristic feature of AFRS. Lactophenol Cotton Blue 
(LPCB) stain was used to identify the fungal species. Solid tissue specimens were fixed 
with 10% buffered formalin and embedded in paraffin in order to obtain tissue sections 5-
6 micrometers in thickness. Hematoxylin and eosin staining of the sections were done for 
routine histologic evaluation. Representative sections were also stained with Gomori 
Methenamine Silver stain (GMS), Periodic Acid-Schiff stain (PAS) and Fontana – 
Masson stain which are special stains for fungal organisms. 
 
For fungal culture the specimens obtained were transported in saline or moistened gauze 
and cultured on mould-inhibitory agar and Sabouraud’s dextrose agar at 30°C.  The 
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fungal moulds grew in 2 weeks and were brown and black in colour with a pigmented 
surface.  Microslide culture technique was then used to identify the fungus. 
 
Laboratory Techniques for Nasal Swab: 
Two nasal swabs were taken from the middle meatus of the discharging nasal cavities in 
a sterile test tube. Nasal swabs in all cases were collected before administering any local 
medication. 
 
One of the swabs was cultured on 2% blood agar aerobically and anaerobically at 37°C 
and examined for growth at the end of 24 hours and 48 hours. Morphology, colony and 
cultural characteristics and standard biochemical reactions were the basis of identification 
of the organisms (Cruickshank, 1965). Standard disc technique as recommended by 
W.H.O (1961) was used to test the antibiotic sensitivity of these strains that were 
obtained from the nasal swab cultures.  
 
The other swab was used for the purpose of mycological examination. Direct 
demonstration of fungal elements was demonstrated in a potassium hydroxide 
preparation. Irrespective of the results of KOH preparation, the second nasal swab was 
cultured on Sabouraud’s dextrose agar plates. Caution was taken at every step of 
inoculation to avoid aerial contamination. After inoculation, the culture tubes were 
incubated at 37°C for 10 days. Examination was done on a daily basis to assess the 
pattern of fungal growth at the site of inoculation. To suppress bacterial growth it was not 
necessary to add antibiotic to this medium since the medium had a low pH which was 
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sufficient to inhibit superadded growth of bacterial pathogens. Usually fungal growth was 
obtained after 3-5 days of incubation. As a routine practice, the culture tubes were 
retained for a period of four weeks before discarding them as negative. 
 
Some of the most commonly seen species were identified by the typical microscopic 
features like Aspergillus species were identified by the presence of typical conidiophores, 
Mucor by the presence of right-angled aseptate hyphae and Candida species which appear 
as budding yeasts and occasionally with pseudohyphae.  
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RESULTS 
In this study, analysis of 100 patients with chronic rhinosinusitis was done in the 
Department of E.N.T, PSG Institute of Medical Sciences & Research from July 2011 to 
July 2013 to determine the incidence of fungal sinusitis. Detailed evaluation of each case 
was done comprising of the history, clinical examination, investigations, histopathology 
and microbiology examination. Medical or surgical treatment or a combination of both 
and follow-up were done for all cases. 
 
The clinical data was collected by means of a proforma and the observations made were 
analyzed with the Master Chart as shown in the Annexure. 
 
The results have been evaluated primarily keeping in mind the aims of the study, namely 
to determine the incidence of fungal sinusitis, to study the clinical, radiological and 
microscopic features, to study the aetiological basis, to identify the type of fungus 
prevalent in these fungal infections and to evaluate the results of various treatment 
modalities. 
 
In our study of 100 cases of chronic rhinosinusitis, 30% of cases turned out to have a 
fungal aetiology. 
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Age distribution of fungal rhinosinusitis cases: 
Age (years) 
 
No. of fungal 
sinusitis patients 
Percentage (%) 
11-20 1 3.3 
21-30 4 13.3 
31-40 6 20 
41-50 7 23.3 
51-60 3 10 
61-70 
71-80 
81-90 
7 
1 
1 
23.3 
3.3 
3.3 
Total 30 100 
 
 
From the table above it is evident that the maximum incidence of fungal rhinosinusitis 
(23.3%) was in the age group of 41-50 and 61-70 years followed by 20% in 31-40 years 
age groups. Majority of the patients i,e…76.6% were in the age group of 31-70 years. 
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Overall Age distribution in our study: 
Age-wise 
distribution 
Fungus 
Rhinosinusitis 
Non-fungal 
sinusitis 
p value 
<50 yrs (n=74) 18 56   .037 
>50 yrs (n=26) 12 14  
 
 
 
 
 
 
 
 
 
Age-group more than 50 years has got comparatively more number of fungal 
rhinosinusitis cases and the value is statistically significant (p<0.05). 
 
Sex distribution of fungal rhinosinusitis cases: 
Sex No. of cases Percentage (%) 
Male 19 63.3 
Female 11 36.6 
Total  30 100 
  
In our study, the incidence of fungal rhinosinusitis amongst males was 63.3% (19 males) 
and 36.6% in females (11 females). 
 
18
56
12 14
0
10
20
30
40
50
60
Fungus Rhinosinusitis Non-fungal sinusitis
<50 yrs (n=74) >50 yrs (n=26)
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Overall Sex distribution in our study: 
 
 
 
 
 
 
 
 
 
Hence sex of individual is not a statistically significant parameter (p>0.05) in our study. 
 
Occupation distribution of fungal rhinosinusitis cases: 
Occupation 
 
No. of cases Percentage(%) 
Manual labourer 
Farmers 
8 
8 
26.7 
26.7 
Housewife 10 30 
Student 3 10 
Others 1 3.3 
Total 30 100 
19
39
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45
Fungus rhinosinusitis Non-fungal sinusitis
Males Females
Sex Fungus 
rhinosinusitis 
Non-fungal 
sinusitis 
p value 
Males (n=58) 19 39 .479 
Females (n=42) 11 31  
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From the above table we conclude that in our study, maximum number of cases of fungal 
rhinosinusitis were amongst housewives (30%), followed by manual labourers (26.7%) 
and farmers (26.7%). 
 
Clinical features of fungal rhinosinusitis: 
Symptoms Pre operative incidence Percentage (%) 
Nasal obstruction  14 46.6 
Nasal discharge 12 40 
Headache 12 40 
Facial pain 4 13.3 
Swelling over the face 4 13.3 
Recurrent URI 1 3.33 
 
In our study, the incidence of most common symptoms at the time of presentation was 
nasal obstruction (46.6%), nasal discharge (40%) and headache (40%) respectively. The 
other symptoms included facial pain (13.3%), swelling over the face (6.6%) and recurrent 
respiratory tract infections (3.3%). 
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Overall distribution of symptoms in our study population: 
Nasal Obstruction: 
Nasal obstruction Fungus rhinosinusitis Non-fungal 
sinusitis 
p value 
Present (n=72) 22 50 .846 
Absent (n=28) 8  20  
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Hence nasal obstruction as a symptom of fungal rhinosinusitis is not statistically 
significant (p>0.05) in our study. 
 
Nasal discharge: 
Nasal discharge Fungus rhinosinusitis Non-fungal 
sinusitis 
p value 
Present (n=59) 24  35 .005 
Absent (n=41) 6  35  
 
 
Hence nasal discharge as a symptom of fungal rhinosinusitis is statistically significant 
(p<0.05). 
 
Headache: 
Headache Fungus 
rhinosinusitis 
Non-fungal 
sinusitis 
p value 
Present 
(n=56) 
24 32 .002 
Absent 
(n=44) 
6 38  
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Hence headache as a symptom of fungal rhinosinusitis is statistically significant (p<0.05). 
 
Facial swelling: 
Facial 
swelling 
Fungus rhinosinusitis Non-fungal 
sinusitis 
p value 
Present  
(n=4) 
4 0 .003 
Absent  
(n=96) 
26 70  
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Hence facial swelling as a symptom of fungal rhinosinusitis is statistically significant 
(p<0.05). 
 
Systemic diseases associated with fungal rhinosinusitis in relation to the number of 
cases studied: 
 
 
 
 
 
 
From our study, we could conclude that there were no systemic diseases associated with 
16 cases of fungal rhinosinusistis which constitutes to 53.3% of the total number of 
fungal rhinosinusitis cases. Diabetes mellitus was seen associated with as many as 12 
patients (40%). 10 patients (33.3%) were hypertensive. 5 patients (16.6%) were suffering 
from chronic renal failure and 1 patient (3.3%) was suffering from acute 
glomerulonephritis. 
 
The results of our study can be compared with the study done by Emmons et al in 1963 
who stated that Aspergillus infection of maxillary sinus can be found not just among 
debilitated individuals, but also among people in general good health and among 
nutritionally deprived persons. 
 
Medical illness         No. of cases 
Diabetes Mellitus 
Hypertension 
12 
10 
Renal failure 
Acute Glomerulonephritis 
5 
1 
No other illness 16 
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Radiological findings in fungal rhinosinusitis cases: 
Side 
affected 
No. of cases Percentage (%) 
Right 15 50 
Left 10 33.3 
Bilateral  5 16.6 
Total 30 100 
 
In this study, the right side paranasal sinuses are more affected (50%) when compared to 
the left side sinuses (33.3%) according to the radiological findings.  Unilateral 
involvement of sinuses is seen in 25 cases (83.3%) of the cases and only 5 cases (16.6%) 
have bilateral involvement. 
 
12
10
5
1
16
0
2
4
6
8
10
12
14
16
18
No. of cases 
 61 
 
 
 
Overall comparison of radiological findings in our study:  
Radiological 
findings 
Fungus rhinosinusitis Non-fungal 
sinusitis 
p value 
Present (n=78) 23 55 .833 
Absent (n=22) 7 15  
Hence the presence of radiological findings suggestive of fungal rhinosinusitis is not 
statistically significant (p>0.05) in our study. 
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Various fungi isolated during fungal culture from fungal rhinosinusitis cases: 
Fungus No. of cases Percentage (%) 
Aspergillus 05 16.6 
Mucor 02 6.6 
Candida 04 13.3 
Aspergillus + Mucor + Candida 01 3.3 
Mucor + Candida 03 10 
No culture  15 50 
Total 30 100 
 
 
Aspergillus (in 5 cases, 16.6%) was the most common fungus isolated by microbiology 
examination followed by Candida (in 4 cases, 13.3%) and Mucor (in 2 cases, 6.6%). 
Cultures showing mixed growth of Aspergillus, Mucor and Candida were obtained in 
3.3% of cases while a mixed growth of Mucor and Candida was obtained in 10% of 
cases. Negative culture was obtained in 15 cases (50%). 
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Microbiological examination of the study population: 
Microbiology 
examination 
Fungus rhinosinusitis Non-fungal 
sinusitis 
p value 
Positive 
(n=15) 
15 0 .000 
Negative 
(n=85) 
15 70  
Hence the correlation between microbiology examination in diagnosis of fungal sinusitis 
is statistically significant (p<0.05). 
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POSITIVITY Total 
1 2 
MICRO 
1 
Count 15 0 15 
% within MICRO 100.0% 0.0% 100.0% 
2 
Count 15 70 85 
% within MICRO 17.6% 82.4% 100.0% 
Total 
Count 30 70 100 
% within MICRO 30.0% 70.0% 100.0% 
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The sensitivity of microbiological examination in diagnosing fungal rhinosinusitis is 
50%, but specificity is 100%. 
 
Histopathology in fungal rhinosinusitis cases: 
Fungus No. of cases Percentage (%) 
Aspergillus 08 26.6 
Mucor 09 30 
Candida 02 6.6 
Mucor + Aspergillus + Candida 01 3.3 
Mucor + Aspergillus 02 6.6 
Mucor + Candida 01 3.3 
No organisms seen 
Total 
07 
30 
23.3 
100 
 
 
Histopathological examination of specimen from 23 cases showed the presence of fungal 
organisms with Mucor (9 cases, 30%) being the most commonly identified fungus on 
histology, followed by Aspergillus (8 cases, 26.6%) and Candida (2 cases, 6.6%). A 
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mixed growth comprising of Mucor, Aspergillus and Candida was seen in 1 case (3.3%). 
Whereas a mixed growth of Mucor and Aspergillus was seen in 2 cases (6.6%). A mixed 
growth of Mucor and Candida was seen in 1 case (3.3%). No mixed growth of 
Aspergillus and candida was noted in our study. No fungal organisms could be identified 
in 7 cases (23.3%). 
 
Pathological examination of the study population: 
Histopathology 
examination 
Fungus 
rhinosinusitis 
Non-fungal 
sinusitis 
p value 
Positive (n=23) 23 0 .000 
Negative (n=77) 7 70  
 
 
 
 
The correlation between pathological examination in diagnosis of fungal sinusitis is 
statistically significant (p<0.05). 
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Pathology vs Fungal Positivity Crosstabulation 
 POSITIVITY Total 
1 2 
HISTO 
1 
Count 23 0 23 
% within HISTO 100.0% 0.0% 100.0% 
2 
Count 7 70 77 
% within HISTO 9.1% 90.9% 100.0% 
Total 
Count 30 70 100 
% within HISTO 30.0% 70.0% 100.0% 
 
The sensitivity of pathological examination in diagnosing fungal rhinosinusitis is 76.67%. 
 
Modality of treatment for fungal rhinosinusitis: 
Treatment modality  No. of cases 
Only Surgical 7 
Surgery + Medical  19 
Only Medical  4 
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Most of the cases (63.3%) were managed by a combination of surgical debridement 
followed by anti-fungal therapy. Whereas 23.3% of cases were managed by surgery alone 
and only 13.3% of cases were managed by anti-fungal therapy alone. 
 
Complications of fungal rhinosinusistis: 
Complications No. of cases Percentage (%) 
Orbital cellulitis 07 23.3 
Cranial nerve palsies 05 16.6 
Orbital apex syndrome 02 6.6 
Cavernous sinus involvement 02 6.6 
Optic atrophy 01 3.3 
 
 
In our study, orbital cellulitis was the most common complication of fungal rhinosinusitis 
(23.3%), followed by cranial nerve palsies (16.6%), orbital apex syndrome and cavernous 
sinus involvement contributing 6.6% each. 
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Association of complications and fungal species: 
 
 
Fungal sinusitis vs Complications Crosstabulation 
 COMPLICATION Total 
1 2 
Fungal Sinusitis 
1.00 
Count 2 8 10 
% within Fungal Sinusitis 20.0% 80.0% 100.0% 
2.00 
Count 4 4 8 
% within Fungal Sinusitis 50.0% 50.0% 100.0% 
3.00 
Count 1 5 6 
% within Fungal Sinusitis 16.7% 83.3% 100.0% 
4.00 
Count 0 2 2 
% within Fungal Sinusitis 0.0% 100.0% 100.0% 
5.00 
Count 3 0 3 
% within Fungal Sinusitis 100.0% 0.0% 100.0% 
6.00 
Count 1 0 1 
% within Fungal Sinusitis 100.0% 0.0% 100.0% 
Total 
Count 11 19 30 
% within Fungal Sinusitis 36.7% 63.3% 100.0% 
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1- Aspergillus 
2- Mucor 
3- Candida 
4- Aspergillus + Mucor 
5- Mucor + Candida 
6- Aspergillus + Mucor + Candida 
 
Hence complications in fungal rhinosinusitis were more associated with Mucor species.  
 
Immunity status of fungal rhinosinusitis patients: 
Immunity status No. of cases Percentage (%) 
Immunocompromised individuals 13 43.3 
Immunocompetent individuals 17 56.6 
Total  30 100 
 
 
 
Of the total 30 cases of fungal rhinosinusitis worked up in our study, only 13 cases 
(43.3%) were immunocompromised, rest 17 cases (56.6%) were immunocompetent 
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individuals. Amongst the 13 immnocompromised cases, 11 cases were sinonasal 
mucormycosis (i,e...84.6% of immunocompromised cases). Amongst the 
immunocompetent cases, 4 cases were immunocompetent mucormycosis. 
 
Overall immunity levels of the study population: 
Immunity level of 
individuals 
Fungus 
rhinosinusitis 
Non-fungal 
sinusitis 
p value 
Immunocompromised 
(n=29) 
13 16 .039 
Immunocompetent 
(n=71) 
17 54  
 
 
 
Hence immunity level of patients has got a statistical significance (p<0.05) to the 
prevalence of fungal rhinosinusitis. 
 
Overall results among fungal rhinosinusitis patients: 
Amongst the 30 cases of fungal rhinosinusitis, there were 5 cases (10%) of fungal ball 
and 2 cases (6.6%) of chronic indolent fungal sinusitis that are still on regular follow-up.  
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There were 4 cases (13.3%) of fungal rhinosinusitis which showed angioinvasion and 
tissue invasion on histopathology, the aetiology being Mucor and Aspergillus species. 
 
In our study, there were 12 cases (40%) of invasive fungal sinusitis amongst which 4 
cases (33.3% of invasive fungal rhinosinusitis) were invasive mucormycosis. 
 
One case of invasive mucormycosis also had associated ileal mucormycosis for which he 
had undergone surgery. 
 
One patient in our study who was on Itraconazole (following weaning of Amphotericin 
therapy) developed skin rashes which were proven to be itraconazole-induced and 
resolved after discontinuing the drug. 
 
Follow up:  
All the patients were followed up to the best possible extent. However 3 patients were 
lost to follow up. There were 3 patients who succumbed to the disease. All of them were 
cases of invasive mucormycosis who developed renal failure and succumbed to cardio-
pulmonary arrest during the course of treatment with Amphotericin-B.
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                         DISCUSSION 
 
Allergic rhinitis, fungal ball, chronic indolent rhinosinusitis and invasive rhinosinusitis 
belong to the spectrum of sinonasal disorders caused by fungal organisms in human 
beings. 
 
The predisposing factors for sinonasal fungal diseases are: 
 Immune status of the host and underlying co-morbid conditions 
 Environmental factors 
 Local anatomical variations in nose and paranasal sinuses 
 Virulence of fungi 
 
Some parameters which lead to a high index of suspicion of sinonasal diseases are: 
 Young adults 
 Past history of poor response to medical management 
 History of multiple surgical interventions in the past 
 Recurrent sinonasal polyposis 
 History of bronchial asthma and atopy 
 Involvement of multiple sinuses 
 Inspissated, viscid mucus in the sinonasal cavities 
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Sinonasal fungal disease may present in different forms as a fungus ball, slowly invasive 
sinonasal disease or in immunocompromised patients, as an acute fulminant infection 
with invasion of underlying tissues and vascular channels. Aspergillus species seem to be 
responsible for the more benign extramucosal sinonasal disease while the fulminant 
entity is usually due to Mucor species. 
 
Usual presentation of FRS is similar to chronic rhinosinusitis which poorly responds to 
antibiotic therapy. There may also be a history of multiple surgeries in the past for his 
complaints. However in most cases, a fungal aetiology is only suspected during surgery 
based on intraoperative findings or sometimes only after pathological or microbiological 
evaluation.  
 
Review of literature and our experience gained during the course of study indicate 
confusion in the presentation of patients with chronic fungal rhinosinsusitis and hence 
causing dilemma while managing such a disease entity. On the contrary, the management 
of acute fungal rhinosinusitis in immunocompromised individuals and paranasal 
mucormycosis is more clearly defined inspite of a poor prognosis. Some of the main 
reasons for the lack of understanding of this disease entity have been the infrequency in 
the incidence of this entity and the lack of long term follow-up of these patients in 
understanding the natural history of illness. However advances in imaging modality 
including computerized tomography and magnetic resonance imaging have contributed a 
great deal in better understanding of the spectrum of sinonasal diseases and even 
contributes to distinguishing one clinical entity from another. Still very little is known 
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about the pathogenesis of fungal rhinosinusistis. However at the end of our study we 
realize that logical treatment plans can be derived from our existing knowledge about the 
disease though there exists some lacunae in our understanding of the disease per se. The 
management protocol also depends on the exact identification of the fungal species and 
susceptibility of the organisms to antifungal agents.  
 
Age:   
Waxman et al17 in 1987 described allergic fungal rhinosinusitis as mostly affecting 
individuals in younger age groups. Milosev and Mahgoub3 in 1967 found that 
Aspergillus rhinosinusitis occurs more frequently in males in their teens and twenties. 
Hartwick and Batsakis35 in 1991 reported 32 cases of AFRS caused by Aspergillus in 
the ages of 8-56 years.  In 1982, Bassiouny et al10 1982 identified six different species of 
fungus from different cases and the individuals were all between 24-44 years. 
 
In contrast to the results of the studies done by Waxman et al17 and Milosev and 
Mahgoub3, in our study majority of the patients (76.6%) were in the age group of 31-70 
years. On further investigating the cause for a higher incidence in 3rd – 7th decade of life, 
we realized that type-2 diabetes mellitus could have played a major role in determining 
immunity status of such individuals. Out of 18 patients in this age group, 9 were diabetic 
individuals (maturity-onset diabetics) with relatively poor glycemic control. There was 
no past history of diabetes mellitus in any patient below the age of 30 years in our study.  
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From our study we conclude that there were proportionately more fungal rhinosinusitis 
cases among those who are in the age group more than 50 years when compared with 
those in the age group less than 50 yrs and this value is statistically significant (p<0.05). 
 
In 1984, Hazarika et al12 in his case series noted that incidence of fungal sinusitis was 
common in older age groups. 
 
The younger generation taking to industrialization and the older members of the family 
becoming entitled to perform agricultural work is probably the reason for higher 
incidence of fungal rhinosinusitis in the older age group in our case series. 
 
Sex: 
In our study there were eleven females (36.6%) and nineteen males (63.3%). A higher 
incidence of fungal rhinosinusitis was noted among females in the study done by 
McGuirt and Harill7 in 1976. In 1991, Hartwick and Batsakis35 published a case study of 
32 cases of allergic fungal rhinosinusitis (Aspergillus) with female predominance. In 
Mayo Clinic, Cody et al45 conducted a study on 100 patients, in which 53% of patients 
were males showing a slight male predominance. In yet another study conducted by 
Manning et al37 the reported incidence of allergic fungal rhinosinusitis had a female 
dominance. 
 
From our study, we conclude that sex of an individual is not a statistically significant 
(p>0.05) parameter in considering the susceptibility to fungal rhinosinusitis. 
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Occupation: 
A case series published from Sudan by Milosev and Mahagoub3 in 1969 showed a higher 
incidence of fungal rhinosinusitis among farmers. In their case series seven patients were 
farmers. In yet another study done by Henderson2 in 1968, five patients were associated 
with agriculture with a history suggestive of exposure to Aspergillus spores. 
 
In our study, considering the cases of fungal rhinosinusitis, we found the number of 
farmland workers and manual labourers was eight each (26.7% each), whereas the 
number of housewives was 10 (30%) which was marginally higher. Thus from our study, 
we found that occupation has no significant role in contributing to the incidence of fungal 
rhinosinusitis. However we noted that patients from a low socio-economic status and 
those suffering from malnutrition and anaemia have a higher chance of acquiring the 
disease. 
 
Symptoms and signs: 
The anatomy of paranasal sinuses and adjacent structures contribute significantly to the 
symptoms with which the patients present. In our study, the major symptoms included 
nasal obstruction, nasal discharge, headache, facial pain, swelling over the face and 
frequent attacks of upper respiratory tract infections. 
 
According to the study conducted by Prabhakar et al39 in 1992, postnasal discharge and 
headache were the most common symptoms invariably noted in 100% of cases whereas 
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nasal obstruction as a symptom was noted only in 71% of cases, fullness over the cheek 
was the symptomatology in 57% of cases and sneezing in 43% of the patients.   
 
Whereas in another study conducted by Axelsson et al6 in 1978, reported  pain over the 
cheek in 50%, cacosmia in 50%, epistaxis in 25% and nasal discharge in 5% of cases.   
 
Morgan et al13 noted nasal obstruction as the predominant symptom in 100% of cases, 
facial pain or headache in 50% and nasal discharge in 50% of individuals in his case 
series comprising of six cases done in 1984. 
 
In another research paper which was quoted earlier as well, McGuirt and Harill7 (1979) 
who published a case series of four cases described headache as the major symptom in 
three patients i,e…75% of the study population, nasal discharge as a symptom in two 
patients and  postnasal discharge in two cases contributing 50% each. 
 
In our study, the most common symptom encountered was nasal obstruction seen in 22 
patients with fungal rhinosinusitis i,e…73.3% of the fungal rhinosinusitis cases included 
in our study. Our results are comparable with those of the study done by Prabhakar et 
al39, which was yet another study undertaken in our country. However in our case series 
nasal obstruction as a symptom of fungal rhinosinusitis is not statistically significant 
(p>0.05). 
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The second most frequent symptom in our case series considering all cases of fungal 
rhinosinusitis was nasal discharge i.e., twenty four patients (80%). Our results are 
comparable to the previous studies done by Morgan et al13 in 1984, Axelsson et al6 in 
1978 and McGuirt and Harill7 in 1979. In all the above mentioned studies, nasal 
discharge was seen in 50% of the study population. 
 
In our case series, the association of nasal discharge as a symptom in cases of fungal 
rhinosinusitis is statistically significant (p<0.05). 
 
Headache was also an equally prevalent symptom as nasal discharge seen in as many as 
24 patients of fungal rhinosinusitis i,e…80% of fungal rhinosinusitis cases. Our results 
are comparable to the observation made by Morgan et al13 in his study in which 50% of 
the individuals presented with complaints of headache. 
 
In our study, there is significant correlation between headache as a symptom and 
incidence of fungal rhinosinusitis. Prevalence of headache as a symptom of fungal 
rhinosinusitis is statistically significant (p <0.05). 
 
In our study facial swelling was noted in four cases of fungal rhinosinusitis i,e…13.3% of 
cases. In all cases, the aetiology was found to be Mucor species. Our result was 
comparable to the results of the study done by Hazarika et al12 in 1984 where he reported 
three cases of mucormycosis, with cheek swelling being a feature of all the cases. Other 
studies don’t make a mention of facial swelling as a presenting symptom. Hence in any 
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chronic rhinosinusitis patient presenting with facial swelling, it is therefore important to 
consider the possibility of sinonasal mucormycosis. 
 
Facial swelling as a symptom of fungal rhinosinusitis is statistically significant (p<0.05) 
in our study. But however, facial pain and recurrent upper respiratory tract infections as 
symptoms of fungal rhinosinusitis were not statistically significant (p>0.05).  
 
Diagnostic nasal endoscopic findings: 
Considering the diagnostic nasal endoscopic findings in our study there were thirteen 
patients who had nasal polyps (43.3%) at the time of presentation. Nine patients had 
purulent nasal discharge (30%) and four had black eschar (13.3%) formation when they 
presented to us. 
 
From our review of literature, we realized there are no established criteria for diagnosing 
fungal rhinosinusitis based on diagnostic nasal endoscopy findings. Hence we hope the 
observations made during our study will help in formulating criteria for diagnosis of FRS 
by diagnostic nasal endoscopy. 
 
Radiology: 
Considering the radiology findings in our study, in majority of the cases of fungal 
rhinosinusistis the maxillary sinus was most commonly involved in as many as 14 cases 
(46.6%), followed by involvement of ethmoids in 12 cases i,e…in 40% of cases and 
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involvement of the sphenoid sinuses was noted in 36.6% cases. Frontal sinus was 
involved in only 2 cases (6.6%). 
 
The results of our study are comparable to the case series of 22 patients of fungal 
rhinosinusitis published by Zinreich et al23 in 1988 in which correlation with CT imaging 
revealed hyper-attenuation of sinuses suggestive of sinusitis. There was involvement of 
the maxillary sinus in 14 patients (63.6%), sphenoid sinus involvement in 10 patients 
(45.4%), ethmoid sinus involvement in seven patients (31.8%) and the frontal sinus was 
involved in three patients (13.6%). 
 
In the study by Blitzer et al8 (1980) in which nine cases of fungal sinusitis were 
evaluated, radiographs of eight patients (88.8%) revealed haziness of unilateral maxillary 
and ethmoid sinuses while haziness of frontal sinus (22.2%) and sphenoid sinus (11.1%) 
was noted only in two patients and one patient respectively. 
 
Another study conducted by Morgan et al13 in 1984 reported the radiological findings of 
X-ray paranasal sinuses of six cases of fungal sinusitis which showed haziness of 
unilateral maxillary sinus in five cases (83.3%) and of ethmoid sinus in two cases 
(22.2%). 
 
The study previously quoted by McGuirt and Harill7 assessed X-ray findings of four 
cases of fungal sinusitis which revealed involvement of unilateral maxillary sinus in three 
cases (75%) and involvement of sphenoid sinus in one case (25%). 
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From our review of literature it appears that the maxillary sinus appears to be the most 
commonly involved sinus in fungal rhinosinusitis. Like the above mentioned studies, in 
our case series too, we find that maxillary sinus is the most commonly involved sinus. 
This is probably because the maxillary sinus ostium is located lowest in the middle 
meatus as compared to other sinuses providing easy access to organisms. However the 
overall percentage of maxillary sinus involvement in our study is comparatively lower 
than the studies quoted. 
 
We have observed in our case series that when there is an opacification of unilateral 
paranasal sinus, a high index of suspicion of fungal aetiology needs to be considered. 
This is probably because of the nasal septum acting as a barrier to the spread of infections 
to the contralateral side. However other conditions like chronic bacterial sinusitis, 
tumours involving paranasal sinuses, infections like tuberculosis and other granulomatous 
conditions like Wegeners granulomatosis need to be excluded before coming to a 
diagnosis of fungal rhinosinusitis.  
 
A plain radiograph of paranasal sinuses may reveal a double density appearance of 
maxillary antrum due to deposition of calcium salts like calcium phosphate and calcium 
sulphate which is pathognomonic of fungal sinusitis. This was first described by 
Stammberger et al77 in 1984. 
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Glan et al in 1984, according the results of his case series stated the importance of 
Computed Tomography scan images in diagnosis of sinonasal aspergillosis. In our study 
CT scan imaging of nose and paranasal sinuses was done for all patients to assess the 
patency of the ostiomeatal complex, except for those patients who could not afford the 
cost of the imaging modality. In some cases, the suspicion of fungal sinusitis was 
considered intraoperatively based on the on-table findings. 
 
These are the results and interpretation when we analysed the radiological findings of all 
cases included in our study. We found that there were twenty three cases (76.7%) of 
fungal rhinosinusitis with positive radiology findings. 
 
In our study we observe that positive radiological findings suggestive of fungal 
rhinosinusitis is not statistically significant (p>0.05). 
 
Microbiology and Pathology: 
In our study, the aetiological agent responsible for the infection was identified by fungal 
culture or pathology examination or a combination of both. Mucor was the most 
commonly reported fungus in as many as 15 cases (50%) followed by Aspergillus in 13 
patients (43.3%) and Candida species in 9 cases (30%). This is contrary to the studies 
done earlier in this part of our country which revealed Aspergillus species to be the 
commonest cause of fungal rhinosinusitis. 
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Axellson and Carlsoo6 in 1978 in his study confirmed the diagnosis by microscopic 
examination of specimen and from fungal culture. 
 
Three cases of rhinocerebral mucormycosis were diagnosed in diabetic individuals in the 
case series reported by Hazarika et al12 in 1984. 
 
Another study done in our country was by Chakrabarti et al40 (1992) in North India had 
results which were comparable to our study. He isolated fungi in as many as 50 out of 
119 clinically suspected cases over a two-year period. The most common species isolated 
in his study was Aspergillus. Aspergillus flavus was isolated in as many as 40 cases. 
 
From our study we observe that the correlation of microbiology examination in the 
diagnosis of FRS is statistically significant (p<0.05) and the sensitivity of 
microbiological examination in diagnosing fungal rhinosinusitis is 50%. 
 
Similarly in our study the correlation between pathological examination and fungal 
positivity is statistically significant (p<0.05). The sensitivity of histopathological 
examination in diagnosing fungal rhinosinusitis is 76.67% whereas the specificity is 
100%. Hence, comparing the overall sensitivity, we conclude that in our study 
pathological examination is a more sensitive investigation than microbiological 
examination. 
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In our study, we were able to diagnose the fungal organisms by means of histological 
examination in 23 out of the 30 cases diagnosed (76.6%). Whereas fungal culture was 
able to diagnose fungal organisms only in 15 cases (50%). Histological features of 
angioinvasion and tissue invasion were recorded in 4 out of 30 cases (13.3%).  
 
On reviewing literature and comparing our study to the other mentioned studies, we 
realized that the most common fungal organisms identified in our study i,e…Mucor 
followed by Aspergillus is not in adherence with the results of the other studies, since in 
most of them the common species identified was Aspergillus species. Mucormycosis is 
an opportunistic infection and the presence of a high number of immunocompromised 
individuals in our study i,e…13 cases (43.3%) would have probably influenced the 
outcome of our study. 
 
According to McNulty and Blitzer10, stress factors favour propagation of a 
mucormycotic infection. In individual with ketoacidosis, the fungus derives much of its 
metabolic requirements from a ketone-reductase enzyme system thus it hereby explain 
our results. Aspergillus is abundantly found in the soil, decaying food, fruit, grain and 
plants. 
 
On classifying the fungal sinusitis, it was found that there were three cases of fungal ball, 
two cases of chronic indolent fungal sinusitis and twelve cases (40%) of invasive fungal 
sinusitis among which four cases were invasive mucormycosis. 
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Immunity status of patients: 
Of the 17 immunocompetant cases (56.6%), four cases were mucormycosis. 
Immunocompetant mucormycosis is a rare clinical condition and our review of literature 
revealed very few case series reporting this disease entity. In our study, the prevalence of 
fungal rhinosinusitis was more in immunocompetent than in immunocompromised 
individuals. 
 
Complications of rhinosinusitis: 
In our study, we noticed that as single agents, Aspergillus caused complications in 20% 
of patients, Mucor caused complications in as high as 50% and Candida caused 
complications only in 16.7% of cases. Whereas considering mixed infections, a combined 
infection of Mucor and Candida species and a combination of Aspergillus, Mucor and 
Candida had complications in 100% cases. 
 
Treatment:   
Georgia Nasal and Sinus institute formulated the treatment strategy for AFRS which 
comprised of FESS, tapering doses of oral steroids like prednisolone and intranasal 
steroid sprays. 
 
Ferguson et al64 obtained satisfactory results by combining immunotherapy after surgery. 
Immunotherapy decreases the necessity for corticosteroid therapy in preventing 
recurrences of the disease. 
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For the treatment of chronic invasive fungal sinusitis, Stringer and Ryan67 suggested a 
combined modality approach including surgery and anti-fungal chemotherapy for 6 
weeks. Use of steroids is strictly contraindicated. 
 
Ferguson64 proposed that fungal balls should be managed surgically, either endoscopic or 
Caldwell-Luc approach. Also stated that mainstay of treatment of mucormycosis includes 
reversal of immunocompromised state of the affected individual, systemic amphotericin-
B and surgical debridement.  
 
Twenty-six out of our thirty cases of fungal rhinosinusitis underwent debridement by 
functional endoscopic sinus surgery, to ensure drainage and ventilation of paranasal 
sinuses. Twelve patients were started on antifungal agent intravenous Amphotericin-B for 
a period of six weeks at 0.7mg/kg/day. Monitoring of renal parameters and serum 
electrolytes was done during administration of intravenous Amphotericin-B. Intravenous 
Amphotericin-B was gradually tapered and patients were started on Itraconazole for six 
weeks. Four patients did not undergo surgery due to financial constraints and were lost to 
further follow up. 
 
Combined modality treatment offered a better treatment outcome as compared to those 
who were treated either medically or surgically. 
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There were two cases of invasive mucormycosis with intracranial extension. One case 
was associated with ileal mucormycosis. Three patients who had invasive mucormycosis 
later succumbed to cardiopulmonary arrest. 
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               LIMITATIONS OF THE STUDY 
 
 
1. Nasal obstruction as a symptom of fungal rhinosinusitis is not statistically significant 
according to our study. However this could have been probably because nasal obstruction 
was present in 71.4% of non-fungal sinusitis patients, hence influencing the outcome of 
our study. 
 
2. Contrary to other studies, Mucor was the commonest aetiological agent in our study. 
This is probably because mucormycosis is an opportunistic infection and we had a large 
number of immunocompromised individuals in our study who were more susceptible to 
this infection. 
 
3. The reason for a lower sensitivity of microbiological examination in diagnosis of 
fungal rhinosinusitis could have been due to inadequate sampling. 
 
4. In few cases, fungal aetiology was suspected only during surgery based on 
intraoperative findings and at times, only after pathological or microbiology evaluation, 
so a complete pre-operative work-up for fungal rhinosinusitis including diagnostic nasal 
endoscopy could not be done in such cases. 
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         CONCLUSIONS 
1. The prevalence of fungal rhinosinusitis in our study is 30%   
2. The prevalence of fungal rhinosinusitis was higher in the elderly age group. 
3. Nasal discharge, nasal obstruction and headache were the most common symptoms of 
fungal rhinosinusitis found in more than 40% of cases of fungal rhinosinusitis. 
4. Maxillary sinus was most commonly involved sinus in cases of fungal rhinosinusitis 
and unilateral involvement of paranansal sinuses was more in favour of fungal 
aetiology.  
5. Mucor was the most common cause of fungal rhinosinusitis followed by Aspergillus 
species. 
6. According to our study, pathological examination has a higher sensitivity (76.67%) as 
compared to microbiology examination (50%) in diagnosis of fungal rhinosinusitis. 
7. In our study 40% of fungal rhinosinusitis were invasive fungal sinusitis. Amongst 
them 33.3% were invasive mucormycosis. 
8. In our study the prevalence of fungal rhinosinusitis was more among 
immunocompetent than immunocompromised individuals. Amongst the 
immnocompromised cases, 84.6% cases were sinonasal mucormycosis. 
9. There were four cases of immunocompetent mucormycosis which is a rare clinical 
entity since there are very few case reports in world literature.  
10. Amongst the fungal species, complications were highest in cases of mucormycosis. 
11. Functional endoscopic sinus surgery is an effective first line of management in fungal 
sinusitis. Antifungal chemotherapy combined with surgery offered better treatment 
outcome as compared to surgery or chemotherapy as a single modality of treatment. 
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CLINICAL PHOTOGRAPHS 
 
                  
Figure 1: Eschar noted on the hard palate in a case of invasive sinonasal Mucormycosis 
 
  
Fig. 2 & 3: Soft tissue density lesion with heterogenous hyperdensities in the Left 
maxillary sinus & posterior ethmoids in a case of fungal rhinosinusitis 
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Figure 4: Aspergillus on LPCB staining showing septate hyphae and swollen vesicle 
giving rise to phialides from which chains of conidia arise 
 
         
 
 
Figure 5: Mucor on LPCB staining showing aseptate hyphae branching at 90o and 
absence of rhizoids 
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Figure 6: Mucor on LPCB staining showing broad aseptate hyphae with extension of 
columella into sporangium and aggregation of sporangiospores 
 
 
 
 
Figure 7: Candida on Gram staining showing pseudohyphae and budding blastoconidia 
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Figure 8: H&E stained tissue section showing polypoidal mucosa lined by respiratory 
epithelium with adjacent fungal ball (10X) 
 
 
 
 
              Figure 9: Mucor on PAS stain showing broad aseptate hyphae (400X) 
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ABBREVIATIONS 
CRS – Chronic Rhinosinusitis 
FRS – Fungal Rhinosinusitis 
AFRS – Allergic Fungal Rhinosinusitis 
ABPA – Allergic Bronchopulmonary Aspergillosis 
FESS – Functional Endoscopic Sinus Surgery 
ESS - Endoscopic Sinus Surgery 
FUO – Fever of Unknown Origin 
HEPA - High Efficiency Particulate Air 
KOH – Potassium hydroxide 
PAS – Periodic Acid Schiff 
GMS - Gomori methenamine silver 
H & E – Hematoxylin and Eosin 
LPCB – Lactophenol Cotton Blue 
ELISA – Enzyme linked Immunosorbent Assay 
CFT – Complement Fixation Test 
ID – Immuno-diffusion 
LA – Latex Agglutination 
RIA – Radio Immunosorbent Assay 
FM – Fontana Masson 
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HP F
1 
F
2 
F
3 
R 
1 6 1 1 2 2 2 2 2 2 2 1 2 1 1 2 2 1 
2 6 1 1 1 1 2 2 2 1 1 1 2 1 2 1 2 1 
3 6 1 1 1 1 2 2 2 1 1 1 1 1 2 2 1 1 
4 4 1 1 1 1 2 1 2 1 1 1 1 1 1 1 1 1 
5 2 1 1 1 1 1 2 2 1 1 1 2 1 2 1 2 1 
6 6 2 1 1 1 1 2 2 1 1 1 2 1 2 1 2 1 
7 3 1 1 1 1 2 2 1 2 2 1 1 1 1 2 2 1 
8 1 2 1 1 2 2 2 2 2 2 1 2 1 1 2 2 1 
9 2 2 1 2 1 2 2 2 1 2 1 2 1 1 2 2 1 
10 2 1 1 1 1 2 2 2 1 2 1 2 1 1 2 2 1 
11 5 2 1 1 2 2 2 2 2 1 2 2 1 2 2 1 1 
12 6 1 2 1 1 1 2 2 2 1 2 2 1 1 1 2 1 
13 3 2 1 1 2 2 2 2 2 2 2 1 2 2 2 1 1 
14 4 1 2 1 1 2 2 2 2 2 2 1 2 2 2 1 1 
15 4 1 1 1 1 2 2 2 2 2 2 2 1 2 1 2 1 
16 5 1 2 1 1 1 2 2 2 2 2 1 2 2 1 2 1 
17 4 1 1 1 1 1 1 2 2 1 2 2 1 2 1 2 1 
18 3 2 2 2 1 2 2 2 2 2 1 1 2 1 2 2 1 
19 3 2 2 1 1 1 2 1 2 2 1 2 1 1 2 2 1 
20 3 1 1 1 2 2 2 1 2 2 1 1 2 1 2 2 1 
21 4 2 2 2 1 2 2 2 2 2 1 1 2 2 2 1 1 
22 6 1 1 1 1 1 2 2 1 2 1 1 1 2 1 1 1 
23 5 2 1 1 1 2 2 2 2 1 1 2 1 1 1 2 1 
24 4 1 1 1 1 1 1 2 1 1 1 1 1 2 1 1 1 
25 8 1 1 1 1 2 2 2 1 1 1 1 1 2 1 1 1 
26 4 1 1 1 1 1 1 2 2 1 1 2 1 2 1 2 1 
27 4 2 2 2 1 2 2 2 2 2 1 1 1 1 2 2 1 
28 6 2 1 1 1 2 2 2 2 2 1 1 1 1 2 2 1 
29 2 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 
30 7 1 2 1 1 1 2 2 1 1 1 2 1 2 1 2 1 
31 4 2 1 1 1 2 2 2 2 2 1 2 2 2 2 2 2 
32 4 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
33 5 1 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
34 3 2 2 1 1 2 2 2 2 2 1 2 2 2 2 2 2 
35 4 1 1 2 2 2 2 1 2 2 2 2 2 2 2 2 2 
36 4 1 1 1 2 2 2 2 2 1 1 2 2 2 2 2 2 
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37 3 1 1 1 1 2 2 2 2 2 1 2 2 2 2 2 2 
38 5 1 2 1 1 2 2 2 2 1 1 2 2 2 2 2 2 
39 6 1 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
40 5 2 1 1 2 1 2 2 2 2 1 2 2 2 2 2 2 
41 5 1 1 2 2 2 2 1 2 1 1 2 2 2 2 2 2 
42 4 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
43 4 1 2 1 1 1 2 2 2 2 1 2 2 2 2 2 2 
44 4 1 1 2 2 2 2 1 2 2 1 2 2 2 2 2 2 
45 6 1 1 1 1 2 2 2 2 1 1 2 2 2 2 2 2 
46 5 2 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 
47 2 2 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
48 3 1 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
49 2 1 2 1 1 1 2 2 2 2 2 2 2 2 2 2 2 
50 3 1 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
51 3 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 
52 4 2 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
53 4 2 1 2 1 2 2 2 2 1 1 2 2 2 2 2 2 
54 3 1 2 1 1 2 2 2 2 2 1 2 2 2 2 2 2 
55 4 2 2 1 1 1 2 2 2 2 1 2 2 2 2 2 2 
56 3 1 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
57 4 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 2 
58 3 2 2 1 1 1 2 2 2 1 2 2 2 2 2 2 2 
59 4 2 1 1 2 2 2 2 2 1 1 2 2 2 2 2 2 
60 6 2 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
61 2 2 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
62 2 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
63 3 2 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
64 2 2 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
65 6 2 2 2 1 2 2 2 2 1 2 2 2 2 2 2 2 
66 2 2 1 2 1 1 2 2 2 2 1 2 2 2 2 2 2 
67 3 1 1 1 1 1 2 1 2 2 1 2 2 2 2 2 2 
68 2 2 2 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
69 3 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
70 1 2 2 2 1 1 2 1 2 2 1 2 2 2 2 2 2 
71 4 2 2 1 2 1 2 2 2 1 1 2 2 2 2 2 2 
72 5 1 1 1 1 1 2 2 2 1 1 2 2 2 2 2 2 
73 2 2 2 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
74 4 2 2 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
75 3 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
76 4 2 1 2 2 2 2 2 2 1 1 2 2 2 2 2 2 
77 5 1 2 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
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78 3 1 2 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
79 4 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
80 2 1 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
81 4 2 1 2 2 2 2 2 2 1 1 2 2 2 2 2 2 
82 3 1 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
83 3 1 1 1 2 2 2 1 2 2 1 2 2 2 2 2 2 
84 2 2 1 2 2 1 2 2 2 2 1 2 2 2 2 2 2 
85 4 1 1 2 2 2 2 2 2 1 1 2 2 2 2 2 2 
86 4 2 1 2 1 2 2 1 2 2 1 2 2 2 2 2 2 
87 2 1 2 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
88 3 2 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
89 5 1 1 1 2 2 2 2 2 1 1 2 2 2 2 2 2 
90 3 2 2 1 2 1 2 2 2 2 1 2 2 2 2 2 2 
91 3 1 1 2 1 2 2 2 2 2 1 2 2 2 2 2 2 
92 3 1 2 2 1 1 2 2 2 2 1 2 2 2 2 2 2 
93 4 2 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
94 3 2 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 
95 3 2 1 1 2 2 2 2 2 2 1 2 2 2 2 2 2 
96 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
97 4 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
98 5 1 2 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
99 4 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10
0 
5 2 2 2 1 2 2 2 2 1 1 2 2 2 2 2 2 
 
 
S. No – Serial No. 
     
Ag gp – Age groups 
Code Age groups 
1 11-20 
2 21-30 
3 31-40 
4 41-50 
5 51-60 
6 61-70 
7 71-80 
8 81-90 
                 
S – Sex:  Male - 1, Female - 2 
    
Symptoms of the study:  Present – 1, Absent - 2 
NO – Nasal Obstruction   
ND – Nasal Discharge   
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Ha – Headache    
FP – Facial Pain     
FS – Facial Swelling     
URI – Upper Respiratory Tract Infection 
     
Com – Complications:  Present – 1, Absent – 2 
 
Imm – Immunity level:  Immunocompromised – 1, Immunocompetant - 2  
 
Imag – Imaging findings positive for Fungal sinusitius:  Present – 1, Absent – 2 
 
Mic – Microbiology findings positive for Fungal sinusitius:  Present – 1, Absent - 2 
HP – Histopathology findings positive for Fungal sinusitius:  Present – 1, Absent – 2 
 
F1 – Aspergillus:  Present – 1, Absent - 2 
F2 – Mucor:  Present – 1, Absent - 2 
F3 – Candida:  Present – 1, Absent – 2 
 
R – Result:  Fungal Sinusitis – 1, Non-fungal sinusitis – 2 
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CONSENT FORM 
 
I, Dr. Sandeep Suresh, am  carrying  out  a  study  on  the  Incidence and clinical profile 
of fungal sinusitis in patients diagnosed with chronic rhinosinusitis as a part of my 
research in the Department of E.N.T. 
 I am doing this study so that it is possible to detect early and treat the life 
threatening complications of fungal rhinosinusitis. 
 In this study, nasal discharge is collected for microbiological examination and 
biopsy of tissues is done as part of pathological examination and the sample will not be 
used for any other purpose and the results will be kept highly CONFIDENTIAL. 
 
Having understood the above from my doctor, 
I _________________  aged  _______  years  diagnosed  to  have 
____________________________ have been  explained  the  importance  of testing  for 
Fungal rhinosinusitis. It has also been explained to me that the test results will be 
included in the above mentioned study.  
 
I hereby give full consent to proceed with the investigation. 
 
 
Signature / Left Thumb Impression:                                                      Date:       
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  PROFORMA 
Name  :     Case No. : 
Age  :     Hosp No. : 
Sex  :     IP No.  : 
Occupation :     Date  : 
Address :     Culture/Biopsy No: 
 
Clinical Data: 
 
Symptoms: 
 
Nasal discharge: 
 Onset and duration 
 Appearance and colour 
 Quantity  
 Consistency 
 Smell 
 Precipitating factors if any 
 Whether associated with upper respiratory tract infection 
 If associated with epistaxis or not 
 
Nasal obstruction: 
 Side 
 Onset and duration  
 Progression - intermittent or constant 
 Associated symptoms – relationship to cold 
 History of drug intake 
 History of trauma 
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Facial pain: 
 Side 
 Onset and duration  
 Nature of pain 
 Radiation 
 Precipitating and relieving factors 
 
Headache: 
 Location 
 Onset and duration 
 Number of attacks per day or week or month 
 Type - Intermittent / continuous 
 Severity 
 Radiation 
 Precipitating and relieving factors 
 Association with nausea / vomiting / giddiness / visual disturbances 
 
Allergy: 
 History of atopy 
 Allergen - if patient can identify 
 Seasonal or perennial 
 Whether associated with other conditions like bronchial asthma or hay fever 
 
Throat symptoms: 
 Duration 
 Onset and progression 
 
Ear symptoms: 
 Duration 
 Onset and progression 
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Other Complaints: 
 Nausea / vomiting / vertigo / fever / loss of weight / altered sensorium. 
 
Treatment history: 
 History of any previous surgery for the nose and paranasal sinuses 
 Whether patient symptomatically improved following the procedure 
 History of drug intake – including antibiotics / decongestants antihistamines / 
anti-inflammatory / immunosuppressant drugs. 
 Whether patient has undergone treatment for pulmonary tuberculosis or diabetes 
mellitus.  
 
Past history: 
 History of diabetes / AIDS  
 History of trauma over the face 
 
Personal history: 
 Occupation, personal hygiene  
 Environment / living conditions  
 Socioeconomic status  
 Sleep, appetite, bowel and bladder habits 
 
Family History: 
 History of any similar illness had occurred in the family  
 History of familial diabetes or bronchial asthma. 
 
General physical examination: 
Built & Nourishment  Level of sensorium  
Anaemia  Jaundice 
Cyanosis Edema 
Clubbing Lymphadenopathy 
 112 
 
 
Vital signs: 
 Temperature 
 Pulse 
 Respiratory rate 
 Blood pressure 
 
Ears, Nose and Throat Examination: 
 
Nose and paranasal sinuses: 
 External nasal framework 
 Vestibule 
 Anterior Rhinoscopy: 
Condition of the nasal mucosa 
Nasal discharge 
Deviation of Nasal Septum 
Mucosa and size of the turbinates 
Middle and Inferior meati 
Presence of nasal polyp or any other mass 
 Posterior Rhinoscopy: 
Condition of nasopharyngeal mucosa 
Eustachian tubal orifices 
Any discharge in the nasopharynx 
Presence of polyp / mass 
Choanal patency 
Posterior end of the nasal septum / turbinates 
 Examination of paranasal sinus tenderness 
 
Oral Cavity and Oropharynx: 
 Lips, teeth and gums 
 Buccal mucosa 
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 Hard and soft palate 
 Condition of tonsils 
 Any lymphoid aggregations on the posterior pharyngeal wall 
 
Indirect Laryngoscopy: 
 Assessment of laryngeal and hypopharyngeal mucosa 
 Vocal cords - appearance and movements 
 
Ears: 
 Pinna, Pre- and Post-auricular areas 
 Mastoid or tragal tenderness 
 External auditory canal examination 
 Tympanic membrane appearance 
 Tuning fork tests 
 
Systemic Examination: 
 Cardiovascular system 
 Respiratory system 
 Central Nervous system 
 Abdominal examination 
 
Investigations: 
 Routine Blood - Hb in gm%, PCV 
 Total WBC count, Differential Count, AEC or Absolute Eosinophil Count 
 Erythrocytic Sedimentation Rate 
 Bleeding Time and Clotting Time 
 Blood Sugar – fasting and post prandial 
 Blood grouping and typing 
 Serology for HIV and HBsAg 
 Urine analysis – Albumin / Sugar / Microscopy 
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 Allergic test 
 Diagnostic Nasal Endoscopy 
 Radiological Examination: 
 X-ray paranasal sinuses - Water’s view 
 CT Scan – Nose and paranasal sinuses  
 Discharge for allergic mucin, Gram stain, KOH smear and fungal culture 
 Histopathological examination of specimens 
 
Treatment:  
 Surgery, medical or both 
 
Follow-up: 
 Improvement in symptoms 
 Endoscopic evaluation 
 
 
 
 
 
